Produkty 2143097-10-1

CAS 2143097-10-1 występuje w naszej ofercie pod nazwami: Pomalidomide-PEG2-OH/ 99.98% (existing batch purity), Pomalidomide-PEG2-OH, 2-(2,6-Dioxopiperidin-3-Yl)-4-((2-(2-Hydroxyethoxy)Ethyl)Amino)Isoindoline-1,3-Dione, 95%. Oferty producentów: TargetMol, MedChemExpress, Chemat. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 250 mg.

Pomalidomide-PEG2-OH/ 99.98% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 7
od 757,88
Zobacz produkt
Pomalidomide-PEG2-OH
MedChemExpress
  • opakowanie: 250 mg, 100 mg, 5 mg, 25 mg
  • Warianty: 6
od 528,67
Zobacz produkt
2-(2,6-Dioxopiperidin-3-Yl)-4-((2-(2-Hydroxyethoxy)Ethyl)Amino)Isoindoline-1,3-Dione, 95%
Chemat
  • opakowanie: 50mg, 100mg, 250mg
  • Warianty: 3
od 1125,20
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

2-(2,6-dioxopiperidin-3-yl)-4-[2-(2-hydroxyethoxy)ethylamino]isoindole-1,3-dione (CAS 2143097-10-1) to związek chemiczny o wzorze sumarycznym C17H19N3O6 i masie molowej 361.3 g/mol. Nazwa systematyczna IUPAC: 2-(2,6-dioxopiperidin-3-yl)-4-[2-(2-hydroxyethoxy)ethylamino]isoindole-1,3-dione. InChIKey: TWOVEQMWQFKDIL-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC17H19N3O6
Masa molowa361.3 g/mol
Nazwa IUPAC2-(2,6-dioxopiperidin-3-yl)-4-[2-(2-hydroxyethoxy)ethylamino]isoindole-1,3-dione
InChIKeyTWOVEQMWQFKDIL-UHFFFAOYSA-N
SMILESC1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)NCCOCCO

Dane obliczone przez PubChem (NCBI)

Synonimy: Pomalidomide-PEG2-OH, 2-(2,6-dioxo-3-piperidyl)-4-[2-(2-hydroxyethoxy)ethylamino]isoindoline-1,3-dione, orb1298133, 2-(2,6-dioxopiperidin-3-yl)-4-[2-(2-hydroxyethoxy)ethylamino]isoindole-1,3-dione
Izomery (ten sam wzór sumaryczny)
N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide C17H19N3O6
N-[1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide C17H19N3O6
[(2S,3S,4R,5R)-3-amino-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxyoxolan-2-yl]methyl 4-methylbenzoate C17H19N3O6
[(4S)-2-[6-[(4S)-4-(acetyloxymethyl)-4,5-dihydro-1,3-oxazol-2-yl]-2-pyridinyl]-4,5-dihydro-1,3-oxazol-4-yl]methyl acetate C17H19N3O6
N-[1-[3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]-2-oxopyrimidin-4-yl]benzamide C17H19N3O6
methyl 5-hydroxy-6-oxo-2-[2-(phenylmethoxycarbonylamino)propan-2-yl]-1H-pyrimidine-4-carboxylate C17H19N3O6
N-[1-[(4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]-4-methoxybenzamide C17H19N3O6
methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(E)-N-methoxy-C-methylcarbonimidoyl]benzoate C17H19N3O6
methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(E)-N-methoxy-C-methylcarbonimidoyl]benzoate C17H19N3O6
methyl 2-(4,6-dimethoxypyrimidin-2-yl)oxy-6-[(Z)-N-methoxy-C-methylcarbonimidoyl]benzoate C17H19N3O6
(2R,3R)-2,3-dihydroxybutanedioic acid;(1S,12R)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene C17H19N3O6
4-[2-(2-aminoethoxy)ethoxy]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione C17H19N3O6